Pmv Lifescience Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.72 Cr
as on 16-12-2024
- Revenue 20.76%
(FY 2022)
- Profit 77.77%
(FY 2022)
- Ebitda 91.72%
(FY 2022)
- Net Worth 31.84%
(FY 2022)
- Total Assets 14.23%
(FY 2022)
About Pmv Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.72 Cr.
Harshadrai Mehta, Devendra Mehta, and Yogin Mehta serve as directors at the Company.
- CIN/LLPIN
U15100MH2010PTC208173
- Company No.
208173
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pmv Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogin Mehta  | Director | 25-Sep-2010 | Current |
| Harshadrai Mehta | Whole-Time Director | 25-Sep-2010 | Current |
| Devendra Mehta | Director | 25-Sep-2010 | Current |
Financial Performance of Pmv Lifescience.
Pmv Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.76% increase. The company also saw a substantial improvement in profitability, with a 77.77% increase in profit. The company's net worth Soared by an impressive increase of 31.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pmv Lifescience?
Unlock access to Pmv Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mehta Api Private LimitedActive 37 years 8 monthsHarshadrai Mehta, Devendra Mehta and 1 more are mutual person
Lotus Purity Standard LlpActive 6 years 10 monthsHarshadrai Mehta, Devendra Mehta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kotak Mahindra Bank Limited Creation Date: 21 Aug 2015 | ₹1.72 Cr | Open |
How Many Employees Work at Pmv Lifescience?
Unlock and access historical data on people associated with Pmv Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pmv Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pmv Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
